Search
for

    GlossaryCOVID-19 vaccine

    medical intervention to provide immunity against the coronavirus

    The COVID-19 vaccine, also known as the coronavirus vaccine or SARS-CoV-2 vaccine, is a medical intervention designed to provide immunity against the virus responsible for COVID-19. These vaccines work by stimulating the body's immune system to recognize and fight the virus, typically using mRNA technology, viral vectors, or inactivated virus particles. They have been crucial in reducing the spread of the virus and the severity of the disease.

    Related Terms

    Learn

    0 / 0 results
    — no results

    Research

    5 / 1000+ results

    Community Join

    5 / 397 results

      community Alright so FDA better approve PP405 as fast as they approved covid vaccine

      in Product  127 upvotes 2 months ago
      PP405 is a potential hair loss treatment showing promising early results, with hopes for market release by 2028, but skepticism remains due to inconclusive data and past disappointments with similar products. Current treatments like Minoxidil and Finasteride have side effects, leading some to anticipate PP405 as a safer alternative, though its effectiveness compared to placebo is debated.

      community Goodbye tressless. I’ve decided to give in to my hairloss.

      in Update  596 upvotes 2 years ago
      Kitchen_Plastic_2847 had been fighting hair loss since 2019-2020 and was initially successful in regrowing his hair with finasteride. However, after contracting Covid three times back to back at the start of 2021, he started to lose his hair again. He found a new dermatologist who prescribed him oral minoxidil along with finasteride, but eventually decided it wasn't worth spending all the money to try and save his hair.

      community PP405 timeframe ? Could it replace current treatments ?

      in Update  36 upvotes 2 months ago
      PP405 is a potential new hair loss treatment that might replace finasteride and minoxidil, but it is still in clinical trials and may not be available until 2028-2031. There is skepticism about its effectiveness, with only a 20% increase in hair density observed in some participants.